Childhood and Adolescent Cancer Care at a Tertiary Hospital in Northern Tanzania: A Retrospective Study
JCO Global Oncology · 2023
DOI: 10.1200/go.22.00263 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2023. Verfasst von Esther Majaliwa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology and Oncology Services, Kilimanjaro Christian Medical Centre, Moshi, Tanzania. Hauptthemen laut MEDLINE: Neoplasms, Radiation Oncology. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE Over 400,000 children are diagnosed with cancer around the world each year, with over 80% of these children residing in low- and middle-income countries. This study aims to summarize the epidemiology and care patterns of newly diagnosed childhood cancer patients in Northern Tanzania. METHODS Data from all children and adolescents (age 0-19 years) with newly diagnosed cancers were collected from the Kilimanjaro Cancer Registry located at the Kilimanjaro Christian Medical Centre. Descriptive and inferential analyses were used to compare the demographic and clinical characteristics of the participants over time, stage, and status at last contact. Statistical significance was set at P < .05. Secondary descriptive analysis was conducted on a subset sample with available staging data. RESULTS A total of 417 patients were diagnosed with cancer between 2016 and 2021. There was an increase in the rate of patients with newly diagnosed pediatric cancer each year, particularly among children under age 5 years and 10 years. Leukemias and lymphomas were the leading diagnoses and accounted for 183 (43.8%) of all patients. Over 75% of patients were diagnosed at stage III or above. From a subset analysis of patients with available staging data (n = 101), chemotherapy was the most common treatment (87.1%), compared with radiotherapy and surgery. CONCLUSION There is a significant burden of children with cancer in Tanzania. Our study fills crucial gaps in the literature related to the large burden of disease and survival for children with cancer in the Kilimanjaro region. Furthermore, our results can be used to understand the regional needs and guide research and strategic interventions to improve childhood cancer survival in Northern Tanzania.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pediatric Hematology and Oncology Services, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
- Kilimanjaro Christian Medical University College, Moshi, Tanzania.
- Department of Emergency Medicine, Duke University Medical Center, Durham, NC.
- Duke Global Health Institute, Duke University, Durham, NC.
- Department of Surgery, Duke University Medical Center, Durham, NC.
- University of North Carolina at Chapel Hill, Chapel Hill, NC.
ORCID-Profile: Emily R Smith, Cesia Cotache-Condor, Julia Canick, Kristin Schroeder, Catherine Staton
Förderung
- FIC NIH HHS
Zitieren
APA
Majaliwa, E., Smith, E. R., Cotache-Condor, C., Rice, H., Gwanika, Y., Canick, J., Chao, N., Schroeder, K., Rice, H. E., Staton, C., & Mmbaga, B. T. (2023). Childhood and Adolescent Cancer Care at a Tertiary Hospital in Northern Tanzania: A Retrospective Study. JCO Global Oncology. https://doi.org/10.1200/go.22.00263
Vancouver
Majaliwa E, Smith ER, Cotache-Condor C, Rice H, Gwanika Y, Canick J, et al. Childhood and Adolescent Cancer Care at a Tertiary Hospital in Northern Tanzania: A Retrospective Study. JCO Global Oncology. 2023. doi:10.1200/go.22.00263
BibTeX
@article{Majaliwa2023,
author = {Majaliwa, Esther and Smith, Emily R and Cotache-Condor, Cesia and Rice, Hannah and Gwanika, Yotham and Canick, Julia and Chao, Nelson and Schroeder, Kristin and Rice, Henry E and Staton, Catherine and Mmbaga, Blandina T},
title = {Childhood and Adolescent Cancer Care at a Tertiary Hospital in Northern Tanzania: A Retrospective Study},
journal = {JCO Global Oncology},
year = {2023},
doi = {10.1200/go.22.00263}
}
EUVIMED